Comp Anti-inflammatory effect (%)               Inhibition (%)
  100 µg/ml             200 µg/ml    100 µg/ml     200 µg/ml
IIa 0.042 ± 0.00108 0.0487 ± 0.00039 55.78 48.73
IIb 0.031 ± 0.00083 0.0423 ± 0.00080 66.63 55.47
IIc 0.021 ± 0.00082 0.0321 ± 0.00193 77.15 66.21
IId 0.033 ± 0.00086 0.0473 ± 0.00102 64.73 50.21
IIe 0.028 ± 0.00100 0.0382 ± 0.00095 69.89 59.78
IIf 0.025 ± 0.00097 0.0332 ± 0.00116 72.94 65.05
IIg 0.048 ± 0.00047 0.0528 ± 0.00140 49.26 44.42
IIh 0.017 ± 0.00396 0.0495 ± 0.00285 80 48.21
IIi 0.049 ± 0.00030 0.0558 ± 0.00186 48.42 41.26
IIj 0.023 ± 0.00045 0.0318 ± 0.00017 75.78 66.52
IIk 0.036 ± 0.00023 0.0481 ± 0.00039 62.1 49.36
IIl 0.037 ± 0.00029 0.0216 ± 0.00084 60.42 70.26
IIm 0.029 ± 0.00037 0.0317 ± 0.00062 69.26 66.63
Ibuprofen 0.018 ± 0.00039 0.0225 ± 0.00010 80.42 76.31
Control 0.095 ± 0.00023 0.0950 ± 0.00023 ---- ----
The results are expressed as mean ± SDM (n=6). Significance was calculated by using one-way ANOVA with Dunnet’s t-test.
Table 3: Anti-inflammatory activity by % inhibition of protein denaturation for derivatives (IIa-IIm).